Landon L. Chan

机构：Chinese University of Hong Kong, Prince of Wales Hospital, University of Hong Kong · ORCID：0000-0002-1306-5896

发表论文 77 篇 · 总被引 1526 次 · h-index 16

代表论文

• The Lancet Commission on addressing the global hepatocellular carcinoma burden: comprehensive strategies from prevention to treatment (2025 · The Lancet · 被引 193)
• New targets and new drugs for hepatobiliary cancers (2025 · Journal of Hepatology · 被引 17)
• Comparative Risk of Hepatitis B Virus Reactivation in Patients Receiving Immune Checkpoint Inhibitors or Tyrosine Kinase Inhibitors for Liver Cancer (2025 · Alimentary Pharmacology & Therapeutics · 被引 8)
• Attenuation of the second peak of bimodal recurrence of HBV-related HCC after curative treatment in the antiviral era (2025 · Journal of Hepatology · 被引 7)
• Pattern of failure, impact of local therapy, and characteristics of long-term responders with advanced EGFR mutation positive non-small cell lung cancer treated with first-line osimertinib (2025 · Lung Cancer · 被引 3)
• What’s next after the 2026 BCLC update? (2025 · Journal of Hepatology · 被引 1)